Porphyromonas gingivalis stimulates TACE production by T cells

Oral Microbiology and Immunology

Volumn 24, Issue 2, 2009, Pages 146-151

  Bostanci, N ^b   Reddi, D ^b   Rangarajan, M ^a   Curtis, M A ^a   Belibasakis, G N ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Institute of Dentistry   (United Kingdom)

Author keywords

Periodontitis; Porphyromonas gingivalis; T cells; TACE

Indexed keywords

CYSTEINE PROTEINASE; DOXYCYCLINE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; VIRULENCE FACTOR;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INDUCTION; ENZYME RELEASE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; NONHUMAN; PORPHYROMONAS GINGIVALIS; T LYMPHOCYTE;

ADAM PROTEINS; ADHESINS, BACTERIAL; ANTI-BACTERIAL AGENTS; CULTURE MEDIA, CONDITIONED; CYSTEINE ENDOPEPTIDASES; DOXYCYCLINE; GENE EXPRESSION; HUMANS; JURKAT CELLS; LIPOPOLYSACCHARIDES; PORPHYROMONAS GINGIVALIS; PROTEASE INHIBITORS; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; TOSYLLYSINE CHLOROMETHYL KETONE; VIRULENCE FACTORS;

EID: 60349112390     PISSN: 09020055     EISSN: 1399302X     Source Type: Journal    
DOI: 10.1111/j.1399-302X.2008.00488.x     Document Type: Article

References (45)

1. Slots J, Bragd L, Wikstrom M, Dahlen G. The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults. J Clin Periodontol 1986 : 13 : 570 577.
2. Genco CA, Van Dyke T, Amar S. Animal models for Porphyromonas gingivalis-mediated periodontal disease. Trends Microbiol 1998 : 6 : 444 449.
3. Dixon DR, Darveau RP. Lipopolysaccharide heterogeneity: innate host responses to bacterial modification of lipid a structure. J Dent Res 2005 : 84 : 584 595.
4. Curtis MA, Aduse-Opoku J, Rangarajan M. Cysteine proteases of Porphyromonas gingivalis. Crit Rev Oral Biol Med 2001 : 12 : 192 216.
5. Bostanci N, Allaker R, Johansson U et al. Interleukin-1alpha stimulation in monocytes by periodontal bacteria: antagonistic effects of Porphyromonas gingivalis. Oral Microbiol Immunol 2007 : 22 : 52 60.
6. Bostanci N, Allaker RP, Belibasakis GN et al. Porphyromonas gingivalis antagonises Campylobacter rectus induced cytokine production by human monocytes. Cytokine 2007 : 39 : 147 156.
7. Rautemaa R, Jarvensivu A, Kari K et al. Intracellular localization of Porphyromonas gingivalis thiol proteinase in periodontal tissues of chronic periodontitis patients. Oral Dis 2004 : 10 : 298 305.
8. Reddy P, Slack JL, Davis R et al. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 2000 : 275 : 14608 14614.
9. Moss ML, Jin SL, Milla ME et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997 : 385 : 733 736.
10. Black RA, Rauch CT, Kozlosky CJ et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997 : 385 : 729 733.
11. Lum L, Wong BR, Josien R et al. Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 1999 : 274 : 13613 13618.
12. Robertshaw HJ, Brennan FM. Release of tumour necrosis factor alpha (TNFalpha) by TNFalpha cleaving enzyme (TACE) in response to septic stimuli in vitro. Br J Anaesth 2005 : 94 : 222 228.
13. Gomez MI, Sokol SH, Muir AB, Soong G, Bastien J, Prince AS. Bacterial induction of TNF-alpha converting enzyme expression and IL-6 receptor alpha shedding regulates airway inflammatory signaling. J Immunol 2005 : 175 : 1930 1936.
14. Garton KJ, Gough PJ, Raines EW. Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J Leukoc Biol 2006 : 79 : 1105 1116.
15. Black RA. Tumor necrosis factor-alpha converting enzyme. Int J Biochem Cell Biol 2002 : 34 : 1 5.
16. Kenny PA. TACE: a new target in epidermal growth factor receptor dependent tumors. Differentiation 2007 : 75 : 800 808.
17. Patel IR, Attur MG, Patel RN et al. TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha. J Immunol 1998 : 160 : 4570 4579.
18. Borrell-Pages M, Rojo F, Albanell J, Baselga J, Arribas J. TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J 2003 : 22 : 1114 1124.
19. Kenny PA, Bissell MJ. Targeting TACE-dependent EGFR ligand shedding in breast cancer. J Clin Invest 2007 : 117 : 337 345.
20. Smolen JS, Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2003 : 2 : 473 488.
21. Bostanci N, Emingil G, Afacan B et al. Tumor necrosis factor-alpha-converting enzyme (TACE) levels in periodontal diseases. J Dent Res 2008 : 87 : 273 277.
22. Gemmell E, Yamazaki K, Seymour GJ. The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol 2000 2007 : 43 : 14 40.
23. Taubman MA, Kawai T. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med 2001 : 12 : 125 135.
24. Han X, Kawai T, Taubman MA. Interference with immune-cell-mediated bone resorption in periodontal disease. Periodontol 2000 2007 : 45 : 76 94.
25. Golub LM, Sorsa T, Lee HM et al. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 1995 : 22 : 100 109.
26. Brown DL, Desai KK, Vakili BA, Nouneh C, Lee HM, Golub LM. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial. Arterioscler Thromb Vasc Biol 2004 : 24 : 733 738.
27. Choi DH, Moon IS, Choi BK et al. Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis. J Periodontal Res 2004 : 39 : 20 26.
28. Meli DN, Coimbra RS, Erhart DG et al. Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis. Infect Immun 2006 : 74 : 3890 3896.
29. Gemmell E, Winning TA, Bird PS, Seymour GJ. Cytokine profiles of lesional and splenic T cells in Porphyromonas gingivalis infection in a murine model. J Periodontol 1998 : 69 : 1131 1138.
30. Stashenko P, Goncalves RB, Lipkin B, Ficarelli A, Sasaki H, Campos-Neto A. Th1 immune response promotes severe bone resorption caused by Porphyromonas gingivalis. Am J Pathol 2007 : 170 : 203 213.
31. Gomez MI, Seaghdha MO, Prince AS. Staphylococcus aureus protein A activates TACE through EGFR-dependent signaling. EMBO J 2007 : 26 : 701 709.
32. Leib SL, Clements JM, Lindberg RL et al. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 2001 : 124 : 1734 1742.
33. Horiuchi K, Kimura T, Miyamoto T et al. Cutting edge: TNF-alpha-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J Immunol 2007 : 179 : 2686 2689.
34. Rousseau S, Papoutsopoulou M, Symons A et al. TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNF alpha in LPS-stimulated macrophages. J Cell Sci 2008 : 121 : 149 154.
35. Ye Z, Gan YH. Flagellin contamination of recombinant heat shock protein 70 is responsible for its activity on T cells. J Biol Chem 2007 : 282 : 4479 4484.
36. Schlondorff J, Becherer JD, Blobel CP. Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem J 2000 : 347 (Pt 1 131 138.
37. Srour N, Lebel A, McMahon S et al. TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity. FEBS Lett 2003 : 554 : 275 283.
38. Holzhausen M, Spolidorio LC, Ellen RP et al. Protease-activated receptor-2 activation: a major role in the pathogenesis of Porphyromonas gingivalis infection. Am J Pathol 2006 : 168 : 1189 1199.
39. Kurz M, Pischel H, Hartung HP, Kieseier BC. Tumor necrosis factor-alpha-converting enzyme is expressed in the inflamed peripheral nervous system. J Peripher Nerv Syst 2005 : 10 : 311 318.
40. Krakauer T, Buckley M. Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines. Antimicrob Agents Chemother 2003 : 47 : 3630 3633.
41. Lauhio A, Salo T, Tjaderhane L, Lahdevirta J, Golub LM, Sorsa T. Tetracyclines in treatment of rheumatoid arthritis. Lancet 1995 : 346 : 645 646.
42. Golub LM, McNamara TF, Ryan ME et al. Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001 : 28 : 146 156.
43. Lavda M, Clausnitzer CE, Walters JD. Distribution of systemic ciprofloxacin and doxycycline to gingiva and gingival crevicular fluid. J Periodontol 2004 : 75 : 1663 1667.
44. Sakellari D, Goodson JM, Kolokotronis A, Konstantinidis A. Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva. J Clin Periodontol 2000 : 27 : 53 60.
45. Tachida Y, Nakagawa K, Saito T et al. Interleukin-1 beta up-regulates TACE to enhance alpha-cleavage of APP in neurons: resulting decrease in Abeta production. J Neurochem 2008 : 104 : 1387 1393.